AX-2026-042942
Adipotide · 2 mg declared · Xi'an Mokemei Biotechnology Co., Ltd. · lot MKM-2606-K4013
- Report ID
- AX-2026-042942
- Compound
- Adipotide
- Compound class
- Metabolic and mitochondrial peptides
- Supplier
- MKM — Xi'an Mokemei Biotechnology Co., Ltd.
- Batch / lot
- MKM-2606-K4013
- Declared label claim
- 2mg
- Laboratory
- VendorInvestigate
- Assay date
- 13 Jul 2026
- Submitted
- 17 Jul 2026
- Quarter
- 2026-Q3
- Submitter
- a.bergstrom
- Sample provenance
- Buyer-sourced
Results
Measured against the index acceptance specification for the metabolic and mitochondrial peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 32 min gradient, 214 nm | 97.04 | % area | ≥ 96.0 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 2.96 | % area | ≤ 4.0 | PASS |
| Largest single impurity | RP-HPLC — open-chain (reduced disulfide, +2 Da) | 1.97 | % area | ≤ 1.00 | FAIL |
| Identity — theoretical monoisotopic mass | calculated from molecular formula | 4095.6238 | Da | — | NOT TESTED |
| Identity — observed monoisotopic mass | LC-MS, high resolution (ESI-TOF/QTOF) | 4095.7012 | Da | — | NOT TESTED |
| Mass accuracy | observed vs theoretical | +18.9 | ppm | ± 15 | FAIL |
| Total peptide content | by difference from the gravimetric mass balance | 86.97 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 84.40 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 2.24 | mg | 2 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 1.891 | mg | 2 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 94.6 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 5.56 | % | ≤ 9.0 | PASS |
| Counter-ion (TFA) | anion-exchange ion chromatography | 6.47 | % | ≤ 12.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 1.00 | % | — | NOT TESTED |
| Endotoxin | not ordered on this submission | not determined | — | ≤ 5.0 | NOT TESTED |
| Sterility | not ordered on this submission | not determined | — | no growth | NOT TESTED |
| Appearance | visual, diffuse light, black and white background | White cake, partially collapsed | — | white to off-white intact cake | FAIL |
| Reconstitution clarity | reconstituted per submitter procedure | Clear after 90 s gentle swirling, no particulates | — | clear, no visible particulates | PASS |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 4.65 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 32 min gradient | 13.58 | min | 13.52 ± 0.35 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.22 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 44,704 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs disulfide-scrambled isomer | 1.78 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | Adipotide — main peak | 13.58 | 4,716,445 | 97.04 | — |
| 2 | open-chain (reduced disulfide, +2 Da) | 12.46 | 95,748 | 1.97 | +2.016 |
| 3 | disulfide-scrambled isomer | 14.05 | 23,329 | 0.48 | 0.000 |
| 4 | truncated KLAKLAK repeat (−781 Da) | 11.85 | 13,609 | 0.28 | -781.512 |
| 5 | trifluoroacetyl adduct (+96 Da) | 14.45 | 11,179 | 0.23 | +95.982 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Mass spectrum and identity
Theoretical monoisotopic mass 4095.6238 Da, computed from C190H332N60O43. All ppm figures on this site are against monoisotopic values — see why that matters.
| Charge | Theoretical m/z | Observed m/z | Δ m/z | Rel. abundance (%) |
|---|---|---|---|---|
| 6+ | 683.6112 | 683.6241 | 0.0129 | 7.7 |
| 5+ | 820.1320 | 820.1475 | 0.0155 | 51.6 |
| 4+ | 1024.9132 | 1024.9326 | 0.0194 | 100.0 |
| 3+ | 1366.2152 | 1366.2410 | 0.0258 | 55.2 |
| 2+ | 2048.8192 | 2048.8579 | 0.0387 | 8.0 |
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 5.56 |
| Counter-ion (TFA) | ion chromatography | 6.47 |
| Residual solvent + inorganic residue | estimated | 1.00 |
| Total peptide content | by difference | 86.97 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 98.13 | 97.04 | divergence +0.65 pp vs batch median |
| Total impurities (% area) | not stated | 2.96 | |
| Largest single impurity (% area) | not stated | 1.97 | |
| Water (%) | not stated | 5.56 | |
| Counter-ion (%) | not stated | 6.47 | |
| Peptide content (%w/w) | not stated | 86.97 | |
| Endotoxin (EU/mg) | 0.37 | not determined | |
| Method stated on certificate | YES | — | column, gradient and wavelength given |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Buyer-sourced
- Evidentiary weight
- Strongest available evidence in this index.
- Chain of custody
- Retail purchase → third-party forwarder (10 d) → laboratory (courier, cold pack, 4 d) → assay.
- Assay date
- 13 Jul 2026
- Submitted to the index
- 17 Jul 2026
- Laboratory
- VendorInvestigate, Riga, Latvia
- Method basis
- 32 min gradient · high-resolution MS
- Verification status
- VERIFIED
Annotations
No annotations on this record. Annotations are short signed technical comments from index contributors; see how to contribute.
Related records
Same batch — lot MKM-2606-K4013 n=2
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042943 | MKM-2606-K4013 | Janoshik | 2026-Q3 | 97.92 | 6.31 | — | Supplier-supplied | 1 | MARGINAL |
Cross-sections
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042943 | MKM | MKM-2606-K4013 | Janoshik | 2026-Q3 | 97.92 | 6.31 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041394 | WWB | WWB-2512-R4093 | Janoshik | 2026-Q2 | 99.53 | 3.42 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041396 | WWB | WWB-2512-R4093 | Janoshik | 2026-Q2 | 98.96 | 3.00 | 94.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041391 | WWB | WWB-2512-R4093 | Kestrel | 2026-Q2 | 98.83 | 3.07 | 98.2 | Supplier-supplied | 4 | FAIL |
| AX-2026-041395 | WWB | WWB-2512-R4093 | Medutest | 2026-Q2 | 99.20 | 3.03 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041392 | WWB | WWB-2512-R4093 | Janoshik | 2026-Q2 | 98.74 | 2.54 | 89.2 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-041399 | WWB | WWB-2512-R4093 | Janoshik | 2026-Q2 | 99.17 | 3.04 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041393 | WWB | WWB-2512-R4093 | VendorInvestigate | 2026-Q2 | 98.32 | 3.35 | 98.7 | Buyer-sourced | 1 | MARGINAL |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042943 | Adipotide | MKM-2606-K4013 | Janoshik | 2026-Q3 | 97.92 | 6.31 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042891 | CJC-1295 (no DAC) | MKM-2603-V2347 | Janoshik | 2026-Q3 | 99.28 | 3.63 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042914 | Gonadorelin | MKM-2604-A2596 | Janoshik | 2026-Q2 | 99.93 | 5.19 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042884 | BPC-157 | MKM-2605-X2575 | Nordanalyt | 2026-Q2 | 98.12 | 2.89 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042946 | Tirzepatide | MKM-2601-L3752 | Medutest | 2026-Q2 | 97.71 | 8.10 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042911 | Gonadorelin | MKM-2604-A2596 | Medutest | 2026-Q2 | 99.08 | 5.55 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042932 | L-Glutathione (reduced) | MKM-2511-F2902 | Janoshik | 2026-Q2 | 98.57 | 8.41 | 92.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042941 | CJC-1295 (no DAC) | MKM-2512-Y3111 | PeptideMeter | 2026-Q2 | 97.85 | 4.89 | — | Supplier-supplied | 2 | FAIL |